Please donate
Please support us
with your donation
Welcome to the Website of the
|
Significant progress to increase diagnosis and monitoring of CML in emerging regionsMany hospitals in developing countries do not have the capability to confirm the diagnosis of CML either by cytogenetics or by molecular tests, which results in patients not being able to access the medication available to enhance and extend their quality of life. Moreover once treatment has started, continued monitoring is essential to detect early evidence of drug resistance, or disease progression, that in many cases could be better managed with a change in therapy.
 Last Updated on Tuesday, 03 April 2012 07:50 |  | 
Perspectives on ERSAP 2011 from a Preceptor and an iCMLf Director
Last Updated on Thursday, 05 April 2012 09:23 | |
March 2012 issue of the iCMLf Newsletter now availableDownload the PDF file here - issues covered:
Last Updated on Tuesday, 03 April 2012 07:21 | |
News from CML clinical research on the iCMLf website
Last Updated on Friday, 23 March 2012 08:53 | |
|
CML – a short history of treatment since the mid-20th century
|
iCMLf-ESH Meeting 2011 – a record number of attendees
Last Updated on Tuesday, 03 April 2012 07:25 | |
Become a member of the iCMLf – help shape our futureThe mission of the iCMLf is to improve outcomes for people with CML globally. Established in 2009 by a leading group of hematologists, the aims of the iCMLf are to foster and coordinate global clinical and research collaborations and to improve CML clinical practice and disease monitoring worldwide. Become a member now!
Last Updated on Thursday, 22 March 2012 01:06 | |
ASH 2011: Summaries of the CML Education Session and Key CML Presentations
Last Updated on Thursday, 22 December 2011 10:36 | |
|
When the International CML Foundation first started to develop its priorities for the International CML Foundation, their founders thought that education and training for clinicians from the emerging regions would be an area where we could make a substantial impact in a cost-effective manner. The clinical preceptorship program has exceeded all expectations. Read both perspectives of 
Clinical reality in CML is in constant change. Thanks to the hard work of clinicians and researchers worldwide, interesting updates about CML diagnostics, treatment and care are constantly published in leading journals. The iCMLf team has now published a new website section on news from CML clinical research, providing you with a selection of interesting new scientific publications on CML. 
The treatment of CML over the last 50 years can be divided into three distinct eras, first cytotoxic drugs, then the choice of allogeneic stem cell transplantation or interferon-alfa (IFN) and most recently the era of tyrosine kinase inhibitors (TKI).
The International CML meeting, co-sponsored by the iCMLf and the European School of Heamatology (ESH), is one of the key scientific activities of the iCMLf each year. The program is configured under the guidance of three iCMLf Directors; John Goldman, Jorge Cortes and Tim Hughes. In 2011 the iCMLf-ESH International CML meeting, held in Estoril Portugal, welcomed a record number of participants. Over 460, physicians, scientists and researchers attended from around the globe. While the majority were Europeans, a record number of Americans attended this year. In total one in five attendees crossed the Atlantic to discuss the latest developments in CML.
Like every year in December, about 21.000 hematologists and health professionals (as well as a small group of patient advocates) convened at the Annual Meeting of the American Society of Hematology (ASH) to hear latest news from clinical trials. The CML Advocates Network has attended the CML sessions and summarized the key presentations and posters on Nilotinib, Dasatinib, Bosutinib, Ponatinib, DCC-2036, Imatinib-Interferon combination, STOP studies, as well as some studies on CML and diabetes or fatigue, complemented by a patients' perspective. Read the - iCMLf Forum 2011: Physicians spotlight challenges of CML management in emerging countries
- iCMLf Virtual Education Program: now also in Spanish and French
- ERSAP Preceptorship Program: 2012 program is now open for applications
- Rowley Prize 2011
- iCMLf Annual Report 2011 available now!
- Patient groups and health professionals celebrate International CML Awareness Day, calling for joint action to improve patients access to diagnosis, treatment and care
- Newsletter No. 4 (may 2011)
- Diagnostic testing and monitoring for CML patients globally: The next challenge for the iCMLf
- iCMLf/ESH meeting on CML, 22-25 September 2011
- Patients network and iCMLf join forces on Paediatric CML on World Childhood Cancer Day